Evidence map›Paper›PMID 26370500›Full record

ArticleThe Journal of cell biology2015

Asymmetric cell division during T cell development controls downstream fate.

Kim Pham, Raz Shimoni, Mirren Charnley, Mandy J Ludford-Menting, Edwin D Hawkins, Kelly Ramsbottom, Jane Oliaro, David Izon, Stephen B Ting, Joseph Reynolds and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. CXCR4 coordinates adhesion, migration, and development of human NK cells.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Frontiers in cell and developmental biology · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Why are cell populations maintained via multiple compartments?Journal of the Royal Society, Interface · 2022
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Fate of a Naive T Cell: A Stochastic Journey.Frontiers in immunology · 2019
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 3 countries.

Kim PhamImmune Signalling Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia Centre for Micro-Photonics, Faculty of Science, Engineering, and Technology, Swinburne University of Technology, Hawthorn, Victoria 3122, Australia.
Raz ShimoniImmune Signalling Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia Centre for Micro-Photonics, Faculty of Science, Engineering, and Technology, Swinburne University of Technology, Hawthorn, Victoria 3122, Australia.
Mirren CharnleyImmune Signalling Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia Centre for Micro-Photonics, Faculty of Science, Engineering, and Technology, Swinburne University of Technology, Hawthorn, Victoria 3122, Australia Industrial Research Institute Swinburne, Faculty of Science, Engineering, and Technology, Swinburne University of Technology, Hawthorn, Victoria 3122, Australia.
Mandy J Ludford-MentingImmune Signalling Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia Centre for Micro-Photonics, Faculty of Science, Engineering, and Technology, Swinburne University of Technology, Hawthorn, Victoria 3122, Australia.
Edwin D HawkinsImmune Signalling Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.
Kelly RamsbottomImmune Signalling Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.
Jane OliaroImmune Signalling Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria 3010, Australia.
David IzonSt. Vincent's Institute of Medical Research, Fitzroy, Victoria 3065, Australia.
Stephen B TingImmune Signalling Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.
Joseph ReynoldsDepartment of Applied Mathematics, School of Mathematics, University of Leeds, Leeds LS2 9JT, England, UK.
Grant LytheDepartment of Applied Mathematics, School of Mathematics, University of Leeds, Leeds LS2 9JT, England, UK.
Carmen Molina-ParisDepartment of Applied Mathematics, School of Mathematics, University of Leeds, Leeds LS2 9JT, England, UK.
Heather MelicharDivision of Immunology and Pathogenesis, Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720.
Ellen RobeyDivision of Immunology and Pathogenesis, Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720.
Patrick O HumbertCell Cycle and Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia Department of Pathology, University of Melbourne, Parkville, Victoria 3010, Australia Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, Victoria 3010, Australia Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria 3010, Australia.
Min GuCentre for Micro-Photonics, Faculty of Science, Engineering, and Technology, Swinburne University of Technology, Hawthorn, Victoria 3122, Australia.
Sarah M RussellImmune Signalling Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia Centre for Micro-Photonics, Faculty of Science, Engineering, and Technology, Swinburne University of Technology, Hawthorn, Victoria 3122, Australia Department of Pathology, University of Melbourne, Parkville, Victoria 3010, Australia Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria 3010, Australia sarah.russell@petermac.org.
Peter MacCallum Cancer Centre · AUSwinburne University of Technology · AUUniversity of Leeds · GBUniversity of California, Berkeley · USSt Vincents Institute of Medical Research · AUUniversity of Melbourne · AU

Funding

Biotechnology and Biological Sciences Research Council BB/F003811/1Biotechnology and Biological Sciences Research Council BB/G023395/1
6 · The paper itself

Abstract

During mammalian T cell development, the requirement for expansion of many individual T cell clones, rather than merely expansion of the entire T cell population, suggests a possible role for asymmetric cell division (ACD). We show that ACD of developing T cells controls cell fate through differential inheritance of cell fate determinants Numb and α-Adaptin. ACD occurs specifically during the β-selection stage of T cell development, and subsequent divisions are predominantly symmetric. ACD is controlled by interaction with stromal cells and chemokine receptor signaling and uses a conserved network of polarity regulators. The disruption of polarity by deletion of the polarity regulator, Scribble, or the altered inheritance of fate determinants impacts subsequent fate decisions to influence the numbers of DN4 cells arising after the β-selection checkpoint. These findings indicate that ACD enables the thymic microenvironment to orchestrate fate decisions related to differentiation and self-renewal.

Indexed as

Asymmetric Cell DivisionCell ProliferationAdaptor Protein Complex alpha SubunitsAnimalsCell CommunicationCell DeathCell DifferentiationCell PolarityCells, CulturedCellular MicroenvironmentCoculture TechniquesIntracellular Signaling Peptides and ProteinsMembrane ProteinsMice, Inbred C57BLMice, KnockoutModels, ImmunologicalAdaptor Protein Complex alpha SubunitsCXCR4 protein, humanIntracellular Signaling Peptides and ProteinsMembrane ProteinsNerve Tissue ProteinsNumb protein, mousePKC-3 proteinProtein Kinase CReceptors, CXCR4scrib protein, mouse

Identifiers

PMID26370500
PMCPMC4576854
OpenAlexW2117937562

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.